93 related articles for article (PubMed ID: 2289769)
1. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices.
Hashizume M; Yamaga H; Kitano S; Sugimachi K
Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices.
Kang JH; Kambayashi J; Sakon M; Shiozaki H; Ogawa Y; Ohshiro T; Mori T
Br J Surg; 1987 Jan; 74(1):50-3. PubMed ID: 3828735
[TBL] [Abstract][Full Text] [Related]
3. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
Bellary SV; Isaacs P
Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
[No Abstract] [Full Text] [Related]
4. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial.
Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K
Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808
[TBL] [Abstract][Full Text] [Related]
5. Platelet aggregability after endoscopic intravariceal injection of 5 per cent ethanolamine oleate into oesophageal varices.
Yamaga H; Hashizume M; Kitano S; Higashi H; Sugimachi K
Br J Surg; 1989 Sep; 76(9):939-42. PubMed ID: 2804591
[TBL] [Abstract][Full Text] [Related]
6. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
[TBL] [Abstract][Full Text] [Related]
7. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
10. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
[TBL] [Abstract][Full Text] [Related]
11. Ethanolamine oleate for esophageal varices.
Med Lett Drugs Ther; 1989 Nov; 31(804):99-100. PubMed ID: 2682155
[No Abstract] [Full Text] [Related]
12. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
[TBL] [Abstract][Full Text] [Related]
13. [Disturbances of pulmonary gas exchange after sclerotherapy for esophageal varices].
Rusiniak K; Szczepanik AB; Ratajczak J; Meissner AJ
Wiad Lek; 1997; 50 Suppl 1 Pt 1():298-302. PubMed ID: 9446371
[TBL] [Abstract][Full Text] [Related]
14. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomized controlled trial comparing sodium tetradecyl sulphate and ethanolamine oleate in the sclerotherapy of bleeding oesophageal varices.
Chan AC; Chung SC; Sung JY; Leung JW; Li AK
Endoscopy; 1993 Oct; 25(8):513-7. PubMed ID: 8287811
[TBL] [Abstract][Full Text] [Related]
16. Over-tube technique and intentional removal of the distal mucosa with repeated injections of 5% ethanolamine oleate to sclerose esophageal varices.
Kitano S; Hashizume M; Sugimachi K
Hepatogastroenterology; 1990 Dec; 37(6):569-70. PubMed ID: 2289770
[No Abstract] [Full Text] [Related]
17. Treatment of esophageal varices: low versus high dose of 5% ethanolamine oleate.
Neeman A; Leiser A; Kadish U
Am J Gastroenterol; 1991 Sep; 86(9):1182-4. PubMed ID: 1882797
[TBL] [Abstract][Full Text] [Related]
18. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
[TBL] [Abstract][Full Text] [Related]
19. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
Tsutsumi M; Takada A
Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
[No Abstract] [Full Text] [Related]
20. Absence of disseminated intravascular coagulation with endoscopic sclerosis of esophageal varices.
Gardner EC; Brooks WS
Gastrointest Endosc; 1982 May; 28(2):67-9. PubMed ID: 7084644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
